US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Replimune Group Inc.

8.63

-0.1400-1.60%

Volume:694.83K

Turnover:6.00M

Market Cap:664.25M

PE:-2.91

High:9.01

Open:8.86

Low:8.42

Close:8.77

Loading ...

Overview Company News Filings

Replimune Group Q3 Pretax Profit USD -65.765 Million

THOMSON REUTERS

Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Group Inc expected to post a loss of 67 cents a share - Earnings Preview

Replimune price target raised to $21 from $17 at H.C. Wainwright

Replimune Group Is Maintained at Outperform by BMO Capital

REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA

Replimune Group Is Maintained at Buy by HC Wainwright & Co.

Replimune Group Says Lead Therapy RP1 Gains US FDA's Priority Review

MT Newswires Live

BRIEF-Replimune Announces Biologics License Application Acceptance And Priority Review For Rp1

Replimune announces BLA acceptance, priority review for RP1

Replimune Announces Biologics License Application Acceptance and Priority Review for Rp1 for the Treatment of Advanced Melanoma

THOMSON REUTERS

Replimune Group Inc - FDA Grants Priority Review for Replimune's Bla With Pdufa Date July 22, 2025

THOMSON REUTERS

Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma

Replimune Group (REPL) Receives a Buy from Barclays

Replimune Group’s Strategic Advances Highlight Promising Potential in Oncolytic Virus Therapy

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRIEF-Replimune Announces RP2 Development Program Advances With First Patients Enrolled In Metastatic Uveal Melanoma And Hepatocellular Carcinoma Clinical Trials

Replimune Announces Rp2 Development Program Advances With First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REPL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REPL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":8.625,"timestamp":1745345124418,"preClose":8.765,"halted":0,"volume":694825,"delay":0,"floatShares":53003420,"shares":77014781,"eps":-2.963833,"marketStatus":"Trading","change":-0.14,"latestTime":"04-22 14:05:33 EDT","open":8.86,"high":9.005,"low":8.42,"amount":5999591.5309999995,"amplitude":0.066743,"askPrice":8.63,"askSize":303,"bidPrice":8.62,"bidSize":181,"shortable":3,"etf":0,"ttmEps":-2.963833,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1532059200000,"exchange":"NASDAQ","adjPreClose":8.765,"preHourTrading":{"tag":"盘前","latestPrice":8.73,"preClose":8.765,"latestTime":"09:29 EDT","volume":8709,"amount":72827.122647,"timestamp":1745328599999},"postHourTrading":{"tag":"盘后","latestPrice":9.2,"preClose":8.765,"latestTime":"19:32 EDT","volume":17119,"amount":150093.655,"timestamp":1745278345228},"volumeRatio":1.092393,"impliedVol":0.6969,"impliedVolPercentile":0.412},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REPL\",,,,,undefined,":{"symbol":"REPL","floatShares":53003420,"roa":"-26.30%","roe":"-50.50%","lyrEps":-3.241615,"volumeRatio":1.092393,"shares":77014781,"dividePrice":0,"high":9.005,"amplitude":0.066743,"preClose":8.765,"low":8.42,"week52Low":4.92,"pbRate":"1.38","week52High":17,"institutionHeld":0,"latestPrice":8.625,"committee":-0.252066,"eps":-2.963833,"divideRate":0,"volume":694825,"delay":0,"ttmEps":-2.963833,"open":8.86,"prevYearClose":12.11,"prevWeekClose":7.995,"prevMonthClose":9.75,"prevQuarterClose":9.75,"fiveDayClose":7.51,"twentyDayClose":11.05,"sixtyDayClose":13.59},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REPL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510379861","title":"Replimune Group Q3 Pretax Profit USD -65.765 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2510379861","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510379861?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:00","pubTimestamp":1739365201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nPLX14097B:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2510796713","title":"Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2510796713","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510796713?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:00","pubTimestamp":1739365200,"startTime":"0","endTime":"0","summary":"IGNYTE-3 confirmatory trial of RP1 plus nivolumab in advanced melanoma is enrolling. Enrolled first patients in trials evaluating RP2 for the treatment of metastatic uveal melanoma and hepatocellular carcinoma. WOBURN, Mass., Feb. 12, 2025  -- Replimune Group, Inc. , a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal third quarter ended December31, 2024 and provided a business update.“Over the past couple of months, we have achieved significant regulatory milestones for RP1 in anti-PD-1 failed melanoma,” said Sushil Patel, Ph.D., CEO of Replimune. “With Priority Review and a PDUFA date set for July 22, 2025, by the FDA, our efforts are focused on ensuring a successful commercial launch of RP1 upon approval. Our commercial strategy is built on a deep understanding of the patient population and prescriber landscape, coupled with a launch model designed to effectively deliver intratumoral t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/replimune-reports-fiscal-third-quarter-130000969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HCC","BK4006","REPL"],"gpt_icon":0},{"id":"2509779161","title":"Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2509779161","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509779161?lang=en_us&edition=fundamental","pubTime":"2025-02-08 05:01","pubTimestamp":1738962060,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., Feb. 07, 2025  -- Replimune Group, Inc. , a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired non-executive employees.The aforementioned inducement awards were approved by the compensation committee of the Company's board of directors in reliance on the employment inducement exception under Nasdaq Listing Rule 5635. While the inducement awards were granted outside of the Company’s 2018 Equity Incentive Plan, the awards will have terms and conditions consistent with those set forth under such plan.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/replimune-announces-inducement-grants-under-210100334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKPKM429.USD","IE00B3QW5Z07.USD","NDAQ","BK4585","REPL","BK4139","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD",".IXIC","LU2095319765.USD","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2509749999","title":"Replimune Group Inc  expected to post a loss of 67 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2509749999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509749999?lang=en_us&edition=fundamental","pubTime":"2025-02-07 22:07","pubTimestamp":1738937226,"startTime":"0","endTime":"0","summary":"Replimune Group Inc  expected to post a loss of67cents a share - Earnings Preview Replimune Group Inc REPL.OQ REPL.O is expected to show no change in quarterly revenue when it reports  results on Febr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL8N3OY1HS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL"],"gpt_icon":0},{"id":"2505094885","title":"Replimune price target raised to $21 from $17 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2505094885","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505094885?lang=en_us&edition=fundamental","pubTime":"2025-01-23 20:06","pubTimestamp":1737633963,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Robert Burns raised the firm’s price target on Replimune  to $21 from $17 and keeps a Buy rating on the shares. The firm expects a “relatively uneventful” FDA review process for RP1 in combination with Opdivo for the treatment of adult patients with advanced melanoma who have previously received an anti-PD1 containing regimen. The clinical impact should readily bolster the approval case, the analyst tells investors in a research note.Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.Replimune announces BLA acceptance, priority review for RP1. Replimune 6.923M share Spot Secondary priced at $13.00","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/replimune-price-target-raised-21-120603998.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/replimune-price-target-raised-21-120603998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["REPL"],"gpt_icon":0},{"id":"2505776795","title":"Replimune Group Is Maintained at Outperform by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2505776795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505776795?lang=en_us&edition=fundamental","pubTime":"2025-01-23 01:24","pubTimestamp":1737566640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REPL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2025 12:24 ET (17:24 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL","BMO"],"gpt_icon":0},{"id":"2505779089","title":"REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2505779089","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505779089?lang=en_us&edition=fundamental","pubTime":"2025-01-23 00:37","pubTimestamp":1737563820,"startTime":"0","endTime":"0","summary":"Replimune Group, Inc. REPL announced that the FDA has accepted the biologics license application  for its lead pipeline candidate, RP1 , in combination with Bristol Myers’ BMY Opdivo  to treat adult patients with advanced melanoma.With the FDA granting a priority review to the BLA, a decision from the regulatory body is expected on July 22, 2025.Shares of REPL were up 16.9% on Jan. 21 following the announcement of the news.The FDA also informed REPL that the agency is not currently planning to hold an advisory committee meeting related to the BLA, as it has not identified any potential review issues at this point.In the past year, shares of Replimune have rallied 50.7% against the industry’s decline of 14.8%.Replimune submitted the BLA for the RP1/Opdivo combo in advanced melanoma in November 2024.In the past 60 days, estimates for Voyager Therapeutics’ loss per share have narrowed from $1.72 to $1.48 for 2025. In the past year, shares of VYGR have plunged 30.9%.In the past 60 days, es","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/repl-stock-rises-fdas-priority-163700715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU2242652126.USD","LU0306806265.USD","LU1868837300.USD","LU0456855351.SGD","LU1989771016.USD","LU2360032135.SGD","LU2133065610.SGD","LU1093756325.SGD","LU1670710661.SGD","VYGR","LU0225771236.USD","LU0306807586.USD","LU0321505868.SGD","BK4139","LU0321505439.SGD","LU0882574055.USD","IE0009355771.USD","LU1261432733.SGD","LU0237698245.USD","IE00BJT1NW94.SGD","LU1032466523.USD","BK4588","LU0114720955.EUR","LU1670711123.USD","LU1323610961.USD","LU1868836591.USD","IE00B2B36J28.USD","LU1291159041.SGD","LU2125154935.USD","LU1670710588.SGD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0225284248.USD","LU1571399168.USD","BK4581","BK4532","BMY","CSTL","LU1868836757.USD","LU1868836914.USD","IE0002141913.USD","LU2242646821.SGD","LU1868837136.USD","LU2125154778.USD","REPL","BK4534","BK4196","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2505881744","title":"Replimune Group Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2505881744","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505881744?lang=en_us&edition=fundamental","pubTime":"2025-01-22 20:49","pubTimestamp":1737550140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REPL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2025 07:49 ET (12:49 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL"],"gpt_icon":0},{"id":"2505098276","title":"Replimune Group Says Lead Therapy RP1 Gains US FDA's Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2505098276","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505098276?lang=en_us&edition=fundamental","pubTime":"2025-01-21 22:25","pubTimestamp":1737469541,"startTime":"0","endTime":"0","summary":"Replimune Group  said Tuesday the US Food and Drug Administration has accepted its Biologics License Application for RP1, or vusolimogene oderparepvec, in combination with nivolumab for advanced melanoma, granting Priority Review with a decision expected by July 22.The company said the application is supported by data from the IGNYTE trial, which evaluated RP1 in patients whose melanoma progressed after anti-PD-1 therapy.A phase 3 confirmatory trial, IGNYTE-3, is ongoing with global enrollment, Replimune added.Shares of the company were up around 27% in recent Tuesday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2505278652","title":"BRIEF-Replimune Announces Biologics License Application Acceptance And Priority Review For Rp1","url":"https://stock-news.laohu8.com/highlight/detail?id=2505278652","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505278652?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:30","pubTimestamp":1737466221,"startTime":"0","endTime":"0","summary":"BRIEF-Replimune Announces Biologics License Application Acceptance And Priority Review For Rp1Jan 21 (Reuters) - Replimune Group Inc REPL.O:REPLIMUNE ANNOUNCES BIOLOGICS LICENSE APPLICATION ACCEPTANCE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA20C5C7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2505278305","title":"Replimune announces BLA acceptance, priority review for RP1","url":"https://stock-news.laohu8.com/highlight/detail?id=2505278305","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505278305?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:20","pubTimestamp":1737465659,"startTime":"0","endTime":"0","summary":"Replimune (REPL) Group announced that the U.S. Food and Drug Administration, FDA, has accepted the Biologics License Application, BLA, for RP1 in c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/replimune-announces-bla-acceptance-priority-review-for-rp1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/replimune-announces-bla-acceptance-priority-review-for-rp1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2505522733","title":"Replimune Announces Biologics License Application Acceptance and Priority Review for Rp1 for the Treatment of Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2505522733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505522733?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:00","pubTimestamp":1737464403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA20C5C7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2505227367","title":"Replimune Group Inc - FDA Grants Priority Review for Replimune's Bla With Pdufa Date July 22, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2505227367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505227367?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:00","pubTimestamp":1737464403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA20C5C7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2505271162","title":"Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271162","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505271162?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:00","pubTimestamp":1737464400,"startTime":"0","endTime":"0","summary":"PDUFA action date of July 22, 2025, with priority review. “There are limited treatment options and a significant unmet need for patients with advanced melanoma who previously received an anti-PD-1 containing regimen,” said Sushil Patel, Ph.D., Chief Executive Officer, Replimune. “The BLA acceptance is an important milestone for Replimune, and we look forward to working closely with the FDA on the review of our application.”AboutRP1RP1 is Replimune’s lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein  and GM-CSF, intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/replimune-announces-biologics-license-application-130000404.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","BK4139","BK4157","REPL","IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE0031619046.USD","AEIS"],"gpt_icon":0},{"id":"2503907966","title":"Replimune Group (REPL) Receives a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2503907966","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503907966?lang=en_us&edition=fundamental","pubTime":"2025-01-16 18:18","pubTimestamp":1737022713,"startTime":"0","endTime":"0","summary":"In a report released today, Peter Lawson from Barclays maintained a Buy rating on Replimune Group (REPL – Research Report), with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/replimune-group-repl-receives-a-buy-from-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/replimune-group-repl-receives-a-buy-from-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2503352208","title":"Replimune Group’s Strategic Advances Highlight Promising Potential in Oncolytic Virus Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2503352208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503352208?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:47","pubTimestamp":1736858822,"startTime":"0","endTime":"0","summary":"Evan Seigerman, an analyst from BMO Capital, has initiated a new Buy rating on Replimune Group (REPL). Evan Seigerman has given his Buy rating due ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/replimune-groups-strategic-advances-highlight-promising-potential-in-oncolytic-virus-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/replimune-groups-strategic-advances-highlight-promising-potential-in-oncolytic-virus-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REPL","BK4139"],"gpt_icon":0},{"id":"2502812473","title":"Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502812473","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502812473?lang=en_us&edition=fundamental","pubTime":"2025-01-11 05:01","pubTimestamp":1736542860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA4F15GW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2502817819","title":"Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502817819","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502817819?lang=en_us&edition=fundamental","pubTime":"2025-01-11 05:01","pubTimestamp":1736542860,"startTime":"0","endTime":"0","summary":"WOBURN, Mass., Jan.  10, 2025  (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ann","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/10/3007915/0/en/Replimune-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NDAQ","REPL","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR",".IXIC","BK4139","BK4588"],"gpt_icon":0},{"id":"2501721776","title":"BRIEF-Replimune Announces RP2 Development Program Advances With First Patients Enrolled In Metastatic Uveal Melanoma And Hepatocellular Carcinoma Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721776?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:05","pubTimestamp":1736341543,"startTime":"0","endTime":"0","summary":"Jan 8  - Replimune Group Inc   :   * REPLIMUNE ANNOUNCES RP2 DEVELOPMENT PROGRAM ADVANCES WITH FIRST PATIENTS ENROLLED IN METASTATIC UVEAL MELANOMA AND HEPATOCELLULAR CARCINOMA CLINICAL TRIALS   * REPLIMUNE GROUP INC - PRIMARY ENDPOINTS OF RP2-202 STUDY ARE OVERALL SURVIVAL AND PROGRESSION FREE SURVIVALSource text:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","REPL"],"gpt_icon":0},{"id":"2501772162","title":"Replimune Announces Rp2 Development Program Advances With First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2501772162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501772162?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA5MQDV3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":79,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REPL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-12","symbol":"REPL","fiscalQuarterEnding":"2024/12","expectedEps":-0.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.79},{"market":"US","date":"2024-11-12","symbol":"REPL","fiscalQuarterEnding":"2024/09","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-08-08","symbol":"REPL","fiscalQuarterEnding":"2024/06","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.78},{"market":"US","date":"2024-05-16","symbol":"REPL","fiscalQuarterEnding":"2024/03","expectedEps":-0.86,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715832000000,"reportTimeType":"pre","actualEps":-0.82},{"market":"US","date":"2024-02-08","symbol":"REPL","fiscalQuarterEnding":"2023/12","expectedEps":-0.94,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1707368400000,"reportTimeType":"pre","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REPL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REPL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1724990400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REPL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REPL","date":"2025-04-21","current":-2.697721,"percent":0.874271,"low":-35.076843,"twenty":-16.791042,"median":-7.358545,"eighty":-3.632653,"high":-1.425849,"avg":-10.542955,"sd":7.714486,"marketCap":615733174},"quantilePoints":[{"date":"2020-04-24","current":-9.689712,"twenty":-17.093301,"median":-14.592063,"eighty":-12.240885,"marketCap":421424975},{"date":"2020-05-01","current":-13.658282,"twenty":-17.061972,"median":-14.587881,"eighty":-12.110059,"marketCap":594025986},{"date":"2020-05-08","current":-16.017516,"twenty":-17.013975,"median":-14.592063,"eighty":-12.240885,"marketCap":696633806},{"date":"2020-05-15","current":-17.079171,"twenty":-17.013975,"median":-14.596329,"eighty":-12.329948,"marketCap":742807325},{"date":"2020-05-22","current":-17.711109,"twenty":-17.093301,"median":-14.624593,"eighty":-12.355469,"marketCap":770291563},{"date":"2020-05-29","current":-15.823722,"twenty":-17.097376,"median":-14.643493,"eighty":-12.369713,"marketCap":688205307},{"date":"2020-06-05","current":-16.139583,"twenty":-17.082759,"median":-14.65753,"eighty":-12.381344,"marketCap":849345561},{"date":"2020-06-12","current":-15.505377,"twenty":-17.06611,"median":-14.754647,"eighty":-12.387028,"marketCap":815970490},{"date":"2020-06-19","current":-16.318281,"twenty":-17.024823,"median":-14.769731,"eighty":-12.389979,"marketCap":858749526},{"date":"2020-06-26","current":-18.741937,"twenty":-17.06611,"median":-14.797598,"eighty":-12.394406,"marketCap":986294428},{"date":"2020-07-02","current":-16.954196,"twenty":-17.101451,"median":-14.820632,"eighty":-12.397439,"marketCap":892214584},{"date":"2020-07-10","current":-16.946546,"twenty":-17.105546,"median":-14.892132,"eighty":-12.41483,"marketCap":891811960},{"date":"2020-07-17","current":-17.359689,"twenty":-17.200761,"median":-14.936155,"eighty":-12.438263,"marketCap":913553651},{"date":"2020-07-24","current":-14.689556,"twenty":-17.182868,"median":-14.977107,"eighty":-12.449348,"marketCap":773037907},{"date":"2020-07-31","current":-15.28551,"twenty":-17.173153,"median":-14.977706,"eighty":-12.461932,"marketCap":804399987},{"date":"2020-08-07","current":-15.786963,"twenty":-17.150299,"median":-14.99745,"eighty":-12.497957,"marketCap":956847813},{"date":"2020-08-14","current":-15.521077,"twenty":-17.105546,"median":-15.019509,"eighty":-12.551424,"marketCap":940732482},{"date":"2020-08-21","current":-15.315016,"twenty":-17.101451,"median":-15.055333,"eighty":-12.619031,"marketCap":928243100},{"date":"2020-08-28","current":-17.269275,"twenty":-17.101451,"median":-15.094278,"eighty":-12.643115,"marketCap":1046690787},{"date":"2020-09-04","current":-15.301721,"twenty":-17.101451,"median":-15.102526,"eighty":-12.654887,"marketCap":927437333},{"date":"2020-09-11","current":-16.219027,"twenty":-17.105526,"median":-15.140954,"eighty":-12.672053,"marketCap":983035227},{"date":"2020-09-18","current":-16.484913,"twenty":-17.085151,"median":-15.177734,"eighty":-12.688212,"marketCap":999150559},{"date":"2020-09-25","current":-14.198296,"twenty":-17.079171,"median":-15.140954,"eighty":-12.730018,"marketCap":860558707},{"date":"2020-10-02","current":-15.620784,"twenty":-17.076609,"median":-15.158001,"eighty":-12.730018,"marketCap":946775731},{"date":"2020-10-09","current":-15.999671,"twenty":-17.056567,"median":-15.208661,"eighty":-12.73144,"marketCap":969740079},{"date":"2020-10-16","current":-27.239989,"twenty":-17.079171,"median":-15.242118,"eighty":-12.74047,"marketCap":1651015722},{"date":"2020-10-23","current":-33.540793,"twenty":-17.161486,"median":-15.249135,"eighty":-12.750922,"marketCap":2032907470},{"date":"2020-10-30","current":-31.025234,"twenty":-17.205559,"median":-15.284323,"eighty":-12.755205,"marketCap":1880439410},{"date":"2020-11-06","current":-30.722655,"twenty":-17.269275,"median":-15.289935,"eighty":-12.760313,"marketCap":2137252251},{"date":"2020-11-13","current":-30.332841,"twenty":-17.358495,"median":-15.301721,"eighty":-12.761373,"marketCap":2110134426},{"date":"2020-11-20","current":-33.028506,"twenty":-17.413245,"median":-15.361336,"eighty":-12.775744,"marketCap":2297661075},{"date":"2020-11-27","current":-34.244199,"twenty":-17.561953,"median":-15.37484,"eighty":-12.816432,"marketCap":2382231917},{"date":"2020-12-04","current":-30.901045,"twenty":-17.613874,"median":-15.407236,"eighty":-12.838852,"marketCap":2149662102},{"date":"2020-12-11","current":-28.482875,"twenty":-17.689474,"median":-15.436133,"eighty":-12.919623,"marketCap":1981439667},{"date":"2020-12-18","current":-26.335592,"twenty":-17.792762,"median":-15.443392,"eighty":-12.942942,"marketCap":1832061822},{"date":"2020-12-24","current":-27.656997,"twenty":-17.833312,"median":-15.458438,"eighty":-12.956155,"marketCap":1923986650},{"date":"2020-12-31","current":-25.205792,"twenty":-17.920221,"median":-15.494801,"eighty":-12.966751,"marketCap":1753466094},{"date":"2021-01-08","current":-28.264843,"twenty":-18.079218,"median":-15.510137,"eighty":-12.974293,"marketCap":1966272070},{"date":"2021-01-15","current":-28.562159,"twenty":-18.261285,"median":-15.518256,"eighty":-12.984598,"marketCap":1986955157},{"date":"2021-01-22","current":-29.288932,"twenty":-18.635844,"median":-15.526131,"eighty":-12.991308,"marketCap":2037513812},{"date":"2021-01-29","current":-25.635248,"twenty":-18.853106,"median":-15.53104,"eighty":-12.994069,"marketCap":1783341663},{"date":"2021-02-05","current":-26.84076,"twenty":-19.504667,"median":-15.567438,"eighty":-13.012644,"marketCap":2017351533},{"date":"2021-02-12","current":-22.819904,"twenty":-21.940848,"median":-15.587711,"eighty":-13.047473,"marketCap":1715143997},{"date":"2021-02-19","current":-23.457055,"twenty":-22.436376,"median":-15.606138,"eighty":-13.066316,"marketCap":1763032268},{"date":"2021-02-26","current":-21.421883,"twenty":-22.436376,"median":-15.622317,"eighty":-13.072547,"marketCap":1610068762},{"date":"2021-03-05","current":-21.842527,"twenty":-22.250798,"median":-15.636738,"eighty":-13.086716,"marketCap":1641684319},{"date":"2021-03-12","current":-21.025984,"twenty":-22.237184,"median":-15.656023,"eighty":-13.114651,"marketCap":1580312943},{"date":"2021-03-19","current":-21.8982,"twenty":-22.080584,"median":-15.667314,"eighty":-13.127516,"marketCap":1645868731},{"date":"2021-03-26","current":-20.512551,"twenty":-22.071406,"median":-15.706391,"eighty":-13.135191,"marketCap":1541723365},{"date":"2021-04-01","current":-19.535174,"twenty":-21.972742,"median":-15.742909,"eighty":-13.178949,"marketCap":1468263687},{"date":"2021-04-09","current":-18.601098,"twenty":-21.919166,"median":-15.779654,"eighty":-13.197111,"marketCap":1398058552},{"date":"2021-04-16","current":-18.533053,"twenty":-21.910845,"median":-15.805723,"eighty":-13.201843,"marketCap":1392944271},{"date":"2021-04-23","current":-19.491873,"twenty":-21.900674,"median":-15.81014,"eighty":-13.203144,"marketCap":1465009145},{"date":"2021-04-30","current":-22.634326,"twenty":-21.910845,"median":-15.823722,"eighty":-13.207951,"marketCap":1701195957},{"date":"2021-05-07","current":-22.170381,"twenty":-21.950473,"median":-15.85094,"eighty":-13.241757,"marketCap":1666325857},{"date":"2021-05-14","current":-21.681693,"twenty":-21.982329,"median":-15.875459,"eighty":-13.250591,"marketCap":1629596018},{"date":"2021-05-21","current":-20.875188,"twenty":-21.982329,"median":-15.901941,"eighty":-13.258245,"marketCap":1688176458},{"date":"2021-05-28","current":-22.460135,"twenty":-22.073242,"median":-15.955897,"eighty":-13.283002,"marketCap":1816351093},{"date":"2021-06-04","current":-18.443015,"twenty":-22.004598,"median":-16.002994,"eighty":-13.28992,"marketCap":1491486656},{"date":"2021-06-11","current":-19.595704,"twenty":-21.95287,"median":-16.012966,"eighty":-13.290718,"marketCap":1584704572},{"date":"2021-06-18","current":-20.402586,"twenty":-21.932997,"median":-16.057318,"eighty":-13.292929,"marketCap":1649957113},{"date":"2021-06-25","current":-22.425554,"twenty":-21.932997,"median":-16.081436,"eighty":-13.298312,"marketCap":1813554555},{"date":"2021-07-02","current":-22.788651,"twenty":-22.105608,"median":-16.100527,"eighty":-13.307038,"marketCap":1842918199},{"date":"2021-07-09","current":-20.212392,"twenty":-22.076913,"median":-16.114408,"eighty":-13.311118,"marketCap":1634576157},{"date":"2021-07-16","current":-18.039574,"twenty":-22.026868,"median":-16.132614,"eighty":-13.319278,"marketCap":1458860385},{"date":"2021-07-23","current":-19.063158,"twenty":-21.955266,"median":-16.139958,"eighty":-13.347051,"marketCap":1541637578},{"date":"2021-07-30","current":-18.912918,"twenty":-21.938023,"median":-16.15228,"eighty":-13.375517,"marketCap":1529487661},{"date":"2021-08-06","current":-16.792794,"twenty":-21.918542,"median":-16.19167,"eighty":-13.387047,"marketCap":1522904883},{"date":"2021-08-13","current":-15.575626,"twenty":-21.911392,"median":-16.205733,"eighty":-13.404574,"marketCap":1412522342},{"date":"2021-08-20","current":-15.560153,"twenty":-21.905623,"median":-16.15308,"eighty":-13.425364,"marketCap":1411119174},{"date":"2021-08-27","current":-16.22547,"twenty":-21.895726,"median":-16.15228,"eighty":-13.431331,"marketCap":1471455393},{"date":"2021-09-03","current":-16.988778,"twenty":-21.874892,"median":-16.19167,"eighty":-13.433519,"marketCap":1540678343},{"date":"2021-09-10","current":-16.514289,"twenty":-21.847873,"median":-16.210444,"eighty":-13.441423,"marketCap":1497647861},{"date":"2021-09-17","current":-16.803109,"twenty":-21.82081,"median":-16.215155,"eighty":-13.475095,"marketCap":1523840328},{"date":"2021-09-24","current":-16.638069,"twenty":-21.723491,"median":-16.238363,"eighty":-13.488815,"marketCap":1508873204},{"date":"2021-10-01","current":-15.240389,"twenty":-21.67427,"median":-16.219027,"eighty":-13.513752,"marketCap":1382120371},{"date":"2021-10-08","current":-15.972753,"twenty":-21.626019,"median":-16.19167,"eighty":-13.533427,"marketCap":1448536985},{"date":"2021-10-15","current":-15.549838,"twenty":-21.540653,"median":-16.15388,"eighty":-13.565594,"marketCap":1410183729},{"date":"2021-10-22","current":-14.961884,"twenty":-21.492962,"median":-16.14312,"eighty":-13.567208,"marketCap":1356863349},{"date":"2021-10-29","current":-15.219759,"twenty":-21.476079,"median":-16.139261,"eighty":-13.574656,"marketCap":1380249481},{"date":"2021-11-05","current":-15.694027,"twenty":-21.451576,"median":-16.135948,"eighty":-13.594071,"marketCap":1568586638},{"date":"2021-11-12","current":-15.689335,"twenty":-21.392191,"median":-16.126343,"eighty":-13.624185,"marketCap":1568117703},{"date":"2021-11-19","current":-16.06937,"twenty":-21.266207,"median":-16.114408,"eighty":-13.633329,"marketCap":1606101416},{"date":"2021-11-26","current":-13.606182,"twenty":-21.237353,"median":-16.104262,"eighty":-13.632281,"marketCap":1359910688},{"date":"2021-12-03","current":-12.977483,"twenty":-21.223934,"median":-16.091557,"eighty":-13.587048,"marketCap":1297073435},{"date":"2021-12-10","current":-12.907106,"twenty":-21.205376,"median":-16.076662,"eighty":-13.56612,"marketCap":1290039414},{"date":"2021-12-17","current":-12.311249,"twenty":-21.124959,"median":-16.069894,"eighty":-13.48331,"marketCap":1230484705},{"date":"2021-12-23","current":-13.517038,"twenty":-21.122485,"median":-16.044742,"eighty":-13.433519,"marketCap":1351000928},{"date":"2021-12-31","current":-12.714743,"twenty":-21.069904,"median":-16.015764,"eighty":-13.41643,"marketCap":1270813091},{"date":"2022-01-07","current":-12.189262,"twenty":-21.03217,"median":-16.010593,"eighty":-13.380684,"marketCap":1218292402},{"date":"2022-01-14","current":-11.199295,"twenty":-21.025984,"median":-15.986212,"eighty":-13.311118,"marketCap":1119347176},{"date":"2022-01-21","current":-9.74015,"twenty":-21.006293,"median":-15.955897,"eighty":-13.293375,"marketCap":973508478},{"date":"2022-01-28","current":-8.731415,"twenty":-20.94976,"median":-15.905705,"eighty":-13.286213,"marketCap":872687513},{"date":"2022-02-04","current":-7.99328,"twenty":-20.910732,"median":-15.895098,"eighty":-13.233597,"marketCap":861987330},{"date":"2022-02-11","current":-7.673724,"twenty":-20.897089,"median":-15.869823,"eighty":-13.195305,"marketCap":827526719},{"date":"2022-02-18","current":-7.047744,"twenty":-20.882104,"median":-15.845206,"eighty":-13.132121,"marketCap":760021687},{"date":"2022-02-25","current":-7.183446,"twenty":-20.847524,"median":-15.829866,"eighty":-13.09789,"marketCap":774655645},{"date":"2022-03-04","current":-6.728188,"twenty":-20.805093,"median":-15.823685,"eighty":-13.048554,"marketCap":725561076},{"date":"2022-03-11","current":-7.157181,"twenty":-20.790794,"median":-15.81014,"eighty":-12.996831,"marketCap":771823266},{"date":"2022-03-18","current":-7.179069,"twenty":-20.744594,"median":-15.804542,"eighty":-12.973236,"marketCap":774183582},{"date":"2022-03-25","current":-6.999592,"twenty":-20.701197,"median":-15.776661,"eighty":-12.940996,"marketCap":754828992},{"date":"2022-04-01","current":-7.99328,"twenty":-20.631971,"median":-15.738739,"eighty":-12.832728,"marketCap":861987330},{"date":"2022-04-08","current":-8.5142,"twenty":-20.531056,"median":-15.706391,"eighty":-12.758307,"marketCap":918162846},{"date":"2022-04-14","current":-7.774406,"twenty":-20.522449,"median":-15.696716,"eighty":-12.748252,"marketCap":838384172},{"date":"2022-04-22","current":-8.01079,"twenty":-20.493993,"median":-15.689335,"eighty":-12.730018,"marketCap":863875582},{"date":"2022-04-29","current":-7.341035,"twenty":-20.416327,"median":-15.662226,"eighty":-12.654887,"marketCap":791649919},{"date":"2022-05-06","current":-6.452407,"twenty":-20.38299,"median":-15.655671,"eighty":-12.538835,"marketCap":695821097},{"date":"2022-05-13","current":-6.491804,"twenty":-20.292997,"median":-15.6402,"eighty":-12.449348,"marketCap":700069666},{"date":"2022-05-20","current":-6.148507,"twenty":-20.245319,"median":-15.637726,"eighty":-12.395603,"marketCap":725745226},{"date":"2022-05-27","current":-6.235809,"twenty":-20.234774,"median":-15.631638,"eighty":-12.379449,"marketCap":736049925},{"date":"2022-06-03","current":-6.809503,"twenty":-20.212392,"median":-15.622317,"eighty":-12.311955,"marketCap":803766518},{"date":"2022-06-10","current":-6.468612,"twenty":-20.203255,"median":-15.607654,"eighty":-12.134279,"marketCap":763529122},{"date":"2022-06-17","current":-6.318953,"twenty":-20.189959,"median":-15.595469,"eighty":-11.992537,"marketCap":745863924},{"date":"2022-06-24","current":-7.699145,"twenty":-20.143355,"median":-15.58377,"eighty":-11.944204,"marketCap":908776307},{"date":"2022-07-01","current":-7.640944,"twenty":-20.124611,"median":-15.580646,"eighty":-11.881776,"marketCap":901906508},{"date":"2022-07-08","current":-8.79249,"twenty":-20.103951,"median":-15.560153,"eighty":-11.848266,"marketCap":1037830394},{"date":"2022-07-15","current":-8.534744,"twenty":-20.061997,"median":-15.550705,"eighty":-11.726024,"marketCap":1007406997},{"date":"2022-07-22","current":-7.782289,"twenty":-20.016455,"median":-15.527958,"eighty":-11.633525,"marketCap":918590306},{"date":"2022-07-29","current":-8.053709,"twenty":-19.98877,"median":-15.522807,"eighty":-11.543915,"marketCap":950627642},{"date":"2022-08-05","current":-7.601167,"twenty":-19.981078,"median":-15.512904,"eighty":-11.450611,"marketCap":1010788047},{"date":"2022-08-12","current":-7.515886,"twenty":-19.970963,"median":-15.503521,"eighty":-11.34073,"marketCap":999447498},{"date":"2022-08-19","current":-7.145097,"twenty":-19.933441,"median":-15.494489,"eighty":-11.242484,"marketCap":950140764},{"date":"2022-08-26","current":-7.108019,"twenty":-19.888487,"median":-15.449739,"eighty":-11.188671,"marketCap":945210090},{"date":"2022-09-02","current":-6.993074,"twenty":-19.816752,"median":-15.442937,"eighty":-10.953866,"marketCap":929925003},{"date":"2022-09-09","current":-6.80768,"twenty":-19.756813,"median":-15.436976,"eighty":-10.890541,"marketCap":905271636},{"date":"2022-09-16","current":-6.110597,"twenty":-19.689634,"median":-15.431329,"eighty":-10.778331,"marketCap":812574976},{"date":"2022-09-23","current":-5.888124,"twenty":-19.622483,"median":-15.403136,"eighty":-10.685646,"marketCap":782990935},{"date":"2022-09-30","current":-6.40352,"twenty":-19.571492,"median":-15.3916,"eighty":-10.533097,"marketCap":851527296},{"date":"2022-10-07","current":-6.407228,"twenty":-19.534008,"median":-15.373891,"eighty":-10.386415,"marketCap":852020363},{"date":"2022-10-14","current":-6.918916,"twenty":-19.530951,"median":-15.351275,"eighty":-10.014098,"marketCap":920063656},{"date":"2022-10-21","current":-7.104311,"twenty":-19.514142,"median":-15.301721,"eighty":-9.807604,"marketCap":944717023},{"date":"2022-10-28","current":-6.700151,"twenty":-19.463693,"median":-15.295377,"eighty":-9.668193,"marketCap":890972683},{"date":"2022-11-04","current":-6.285013,"twenty":-19.412753,"median":-15.286558,"eighty":-9.346952,"marketCap":922168605},{"date":"2022-11-11","current":-7.118947,"twenty":-19.397565,"median":-15.277234,"eighty":-9.233032,"marketCap":1044527547},{"date":"2022-11-18","current":-6.451122,"twenty":-19.391261,"median":-15.249135,"eighty":-9.01396,"marketCap":946540915},{"date":"2022-11-25","current":-6.77656,"twenty":-19.371343,"median":-15.242339,"eighty":-8.798362,"marketCap":994290745},{"date":"2022-12-02","current":-6.888429,"twenty":-19.304205,"median":-15.235232,"eighty":-8.708895,"marketCap":1010704750},{"date":"2022-12-09","current":-9.390679,"twenty":-19.279831,"median":-15.219759,"eighty":-8.63141,"marketCap":1377847325},{"date":"2022-12-16","current":-10.475589,"twenty":-19.272597,"median":-15.211631,"eighty":-8.66615,"marketCap":1537030766},{"date":"2022-12-23","current":-10.317569,"twenty":-19.263359,"median":-15.167534,"eighty":-8.683543,"marketCap":1513845240},{"date":"2022-12-30","current":-10.483297,"twenty":-19.232063,"median":-15.140954,"eighty":-8.703265,"marketCap":1538161768},{"date":"2023-01-06","current":-9.951424,"twenty":-19.172861,"median":-15.102526,"eighty":-8.725785,"marketCap":1460122678},{"date":"2023-01-13","current":-10.814754,"twenty":-19.157758,"median":-15.094278,"eighty":-8.739746,"marketCap":1586794823},{"date":"2023-01-20","current":-10.571943,"twenty":-19.139105,"median":-15.069399,"eighty":-8.744456,"marketCap":1551168282},{"date":"2023-01-27","current":-9.978403,"twenty":-19.098984,"median":-15.054481,"eighty":-8.773977,"marketCap":1464081182},{"date":"2023-02-03","current":-10.9034,"twenty":-19.078394,"median":-15.010475,"eighty":-8.810107,"marketCap":1599801338},{"date":"2023-02-10","current":-9.011098,"twenty":-19.073536,"median":-14.978305,"eighty":-8.917906,"marketCap":1412408501},{"date":"2023-02-17","current":-8.971338,"twenty":-19.066387,"median":-14.977232,"eighty":-8.826962,"marketCap":1406176454},{"date":"2023-02-24","current":-7.156829,"twenty":-19.047944,"median":-14.961884,"eighty":-8.755293,"marketCap":1121768485},{"date":"2023-03-03","current":-7.96649,"twenty":-18.994109,"median":-14.946412,"eighty":-8.688473,"marketCap":1248675626},{"date":"2023-03-10","current":-6.741154,"twenty":-18.947558,"median":-14.924413,"eighty":-8.617499,"marketCap":1056615265},{"date":"2023-03-17","current":-7.084537,"twenty":-18.937613,"median":-14.892132,"eighty":-8.574334,"marketCap":1110437490},{"date":"2023-03-24","current":-7.1496,"twenty":-18.918827,"median":-14.820632,"eighty":-8.464903,"marketCap":1120635385},{"date":"2023-03-31","current":-6.383313,"twenty":-18.90696,"median":-14.796136,"eighty":-8.404346,"marketCap":1000526840},{"date":"2023-04-06","current":-5.967638,"twenty":-18.893903,"median":-14.769731,"eighty":-8.353404,"marketCap":935373620},{"date":"2023-04-14","current":-5.880889,"twenty":-18.876593,"median":-14.754647,"eighty":-8.240934,"marketCap":921776426},{"date":"2023-04-21","current":-6.014628,"twenty":-18.872042,"median":-14.72342,"eighty":-8.237923,"marketCap":942738767},{"date":"2023-04-28","current":-6.058002,"twenty":-18.865271,"median":-14.673543,"eighty":-8.162132,"marketCap":949537364},{"date":"2023-05-05","current":-6.307407,"twenty":-18.84001,"median":-14.642657,"eighty":-8.111975,"marketCap":988629296},{"date":"2023-05-12","current":-6.773685,"twenty":-18.786092,"median":-14.624593,"eighty":-8.085208,"marketCap":1061714212},{"date":"2023-05-18","current":-6.338918,"twenty":-18.760756,"median":-14.598129,"eighty":-8.043545,"marketCap":1104771993},{"date":"2023-05-26","current":-6.368208,"twenty":-18.750284,"median":-14.595028,"eighty":-8.000284,"marketCap":1109876825},{"date":"2023-06-02","current":-6.12621,"twenty":-18.73441,"median":-14.58914,"eighty":-7.976597,"marketCap":1067700350},{"date":"2023-06-09","current":-7.47875,"twenty":-18.702219,"median":-14.527689,"eighty":-7.936373,"marketCap":1303426402},{"date":"2023-06-16","current":-7.962747,"twenty":-18.69597,"median":-14.518235,"eighty":-7.928773,"marketCap":1387779351},{"date":"2023-06-23","current":-7.796994,"twenty":-18.685243,"median":-14.453528,"eighty":-7.888232,"marketCap":1358891355},{"date":"2023-06-30","current":-7.661077,"twenty":-18.667244,"median":-14.399755,"eighty":-7.855942,"marketCap":1335203198},{"date":"2023-07-07","current":-7.004698,"twenty":-18.652142,"median":-14.394793,"eighty":-7.843896,"marketCap":1220806732},{"date":"2023-07-14","current":-6.78922,"twenty":-18.6103,"median":-14.376721,"eighty":-7.822971,"marketCap":1183252336},{"date":"2023-07-21","current":-6.80248,"twenty":-18.564048,"median":-14.344533,"eighty":-7.779136,"marketCap":1185563376},{"date":"2023-07-28","current":-6.594113,"twenty":-18.408435,"median":-14.24963,"eighty":-7.705572,"marketCap":1149248430},{"date":"2023-08-04","current":-6.255847,"twenty":-18.227267,"median":-14.198296,"eighty":-7.665176,"marketCap":1135974257},{"date":"2023-08-11","current":-6.335446,"twenty":-18.127797,"median":-14.118082,"eighty":-7.647887,"marketCap":1150428357},{"date":"2023-08-18","current":-6.198991,"twenty":-17.947873,"median":-14.068648,"eighty":-7.573533,"marketCap":1125649900},{"date":"2023-08-25","current":-6.6311,"twenty":-17.81854,"median":-14.004724,"eighty":-7.50913,"marketCap":1204115013},{"date":"2023-09-01","current":-6.634349,"twenty":-17.717437,"median":-13.953723,"eighty":-7.465927,"marketCap":1204704976},{"date":"2023-09-08","current":-6.367936,"twenty":-17.631427,"median":-13.917117,"eighty":-7.434714,"marketCap":1156327989},{"date":"2023-09-15","current":-6.013801,"twenty":-17.579267,"median":-13.810922,"eighty":-7.397943,"marketCap":1092021994},{"date":"2023-09-28","current":-5.393252,"twenty":-17.366758,"median":-13.743606,"eighty":-7.371559,"marketCap":979339011},{"date":"2023-10-06","current":-5.234053,"twenty":-17.358495,"median":-13.711323,"eighty":-7.341615,"marketCap":950430811},{"date":"2023-10-13","current":-4.792197,"twenty":-17.358973,"median":-13.704061,"eighty":-7.315646,"marketCap":870195808},{"date":"2023-10-19","current":-4.649243,"twenty":-17.359211,"median":-13.6531,"eighty":-7.277231,"marketCap":844237425},{"date":"2023-10-23","current":-4.821437,"twenty":-17.35945,"median":-13.643461,"eighty":-7.266629,"marketCap":875505477},{"date":"2023-10-31","current":-4.6265,"twenty":-17.364158,"median":-13.606182,"eighty":-7.244347,"marketCap":840107682},{"date":"2023-11-10","current":-3.415142,"twenty":-17.32282,"median":-13.521228,"eighty":-7.181695,"marketCap":678001257},{"date":"2023-11-17","current":-3.070058,"twenty":-17.327339,"median":-13.433519,"eighty":-7.15697,"marketCap":609492419},{"date":"2023-11-24","current":-3.090882,"twenty":-17.327339,"median":-13.422358,"eighty":-7.134315,"marketCap":613626573},{"date":"2023-12-01","current":-3.325896,"twenty":-17.327339,"median":-13.311118,"eighty":-7.115651,"marketCap":660283454},{"date":"2023-12-08","current":-2.260895,"twenty":-17.32282,"median":-13.291275,"eighty":-7.101345,"marketCap":448851006},{"date":"2023-12-15","current":-2.308493,"twenty":-17.32282,"median":-13.255017,"eighty":-7.080326,"marketCap":458300501},{"date":"2023-12-22","current":-2.290644,"twenty":-17.32282,"median":-13.177521,"eighty":-7.039837,"marketCap":454756941},{"date":"2023-12-29","current":-2.555407,"twenty":-17.327339,"median":-13.141695,"eighty":-7.025096,"marketCap":507319756},{"date":"2024-01-05","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-7.015385,"marketCap":520312811},{"date":"2024-01-12","current":-2.620854,"twenty":-17.331857,"median":-13.153424,"eighty":-6.998149,"marketCap":520312811},{"date":"2024-01-19","current":-2.27577,"twenty":-17.336375,"median":-13.165154,"eighty":-6.976101,"marketCap":451803973},{"date":"2024-01-26","current":-2.347166,"twenty":-17.331857,"median":-13.153424,"eighty":-6.953227,"marketCap":465978216},{"date":"2024-02-02","current":-2.338242,"twenty":-17.331857,"median":-13.131353,"eighty":-6.92926,"marketCap":464206435},{"date":"2024-02-09","current":-2.257183,"twenty":-17.331857,"median":-13.069432,"eighty":-6.885152,"marketCap":473913707},{"date":"2024-02-16","current":-2.23964,"twenty":-17.304882,"median":-13.00772,"eighty":-6.857169,"marketCap":470230440},{"date":"2024-02-23","current":-2.324431,"twenty":-17.304882,"median":-12.978804,"eighty":-6.834348,"marketCap":488032898},{"date":"2024-03-01","current":-2.508631,"twenty":-17.29598,"median":-12.943915,"eighty":-6.80768,"marketCap":526707203},{"date":"2024-03-08","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.789321,"marketCap":542668028},{"date":"2024-03-15","current":-2.58465,"twenty":-17.29598,"median":-12.874263,"eighty":-6.773685,"marketCap":542668028},{"date":"2024-03-22","current":-2.397526,"twenty":-17.29598,"median":-12.760313,"eighty":-6.739451,"marketCap":503379845},{"date":"2024-03-28","current":-2.412145,"twenty":-17.29598,"median":-12.747585,"eighty":-6.71682,"marketCap":506449234},{"date":"2024-04-05","current":-2.146078,"twenty":-17.304882,"median":-12.701477,"eighty":-6.680523,"marketCap":450586349},{"date":"2024-04-12","current":-2.102221,"twenty":-17.261345,"median":-12.582004,"eighty":-6.649243,"marketCap":441378181},{"date":"2024-04-19","current":-2.037897,"twenty":-17.261345,"median":-12.418128,"eighty":-6.619319,"marketCap":427872868},{"date":"2024-04-26","current":-1.798145,"twenty":-17.253415,"median":-12.311955,"eighty":-6.599292,"marketCap":377534883},{"date":"2024-05-03","current":-1.918021,"twenty":-17.253415,"median":-12.073728,"eighty":-6.568396,"marketCap":402703876},{"date":"2024-05-10","current":-1.967726,"twenty":-17.253415,"median":-11.686636,"eighty":-6.523016,"marketCap":413139799},{"date":"2024-05-17","current":-1.912516,"twenty":-17.253415,"median":-11.471468,"eighty":-6.489603,"marketCap":412709505},{"date":"2024-05-24","current":-1.610839,"twenty":-17.253415,"median":-11.245895,"eighty":-6.455856,"marketCap":347609494},{"date":"2024-05-31","current":-1.451463,"twenty":-17.253415,"median":-11.199295,"eighty":-6.429551,"marketCap":313217035},{"date":"2024-06-07","current":-2.02351,"twenty":-17.253415,"median":-11.019024,"eighty":-6.403667,"marketCap":436661396},{"date":"2024-06-14","current":-2.692322,"twenty":-17.261345,"median":-10.931572,"eighty":-6.396942,"marketCap":580986893},{"date":"2024-06-21","current":-2.239807,"twenty":-17.269275,"median":-10.852478,"eighty":-6.368208,"marketCap":483336876},{"date":"2024-06-28","current":-2.424797,"twenty":-17.29598,"median":-10.804126,"eighty":-6.362258,"marketCap":523256694},{"date":"2024-07-05","current":-2.302419,"twenty":-17.29598,"median":-10.763984,"eighty":-6.338722,"marketCap":496848199},{"date":"2024-07-12","current":-2.823238,"twenty":-17.29598,"median":-10.704911,"eighty":-6.326195,"marketCap":609237841},{"date":"2024-07-15","current":-2.948462,"twenty":-17.29598,"median":-10.672408,"eighty":-6.321564,"marketCap":636260487},{"date":"2024-08-02","current":-3.2357,"twenty":-17.360806,"median":-10.556526,"eighty":-6.30697,"marketCap":698244667},{"date":"2024-08-09","current":-2.934568,"twenty":-17.360806,"median":-10.481741,"eighty":-6.280817,"marketCap":645637192},{"date":"2024-08-16","current":-3.198524,"twenty":-17.360806,"median":-10.336007,"eighty":-6.231015,"marketCap":703710378},{"date":"2024-08-23","current":-3.148838,"twenty":-17.360806,"median":-10.221215,"eighty":-6.160784,"marketCap":692778955},{"date":"2024-08-30","current":-3.434531,"twenty":-17.360806,"median":-10.111004,"eighty":-6.142122,"marketCap":755634639},{"date":"2024-09-06","current":-3.328949,"twenty":-17.360806,"median":-10.055486,"eighty":-6.110199,"marketCap":732405365},{"date":"2024-09-13","current":-3.223367,"twenty":-17.360806,"median":-9.951424,"eighty":-6.072015,"marketCap":709176090},{"date":"2024-09-20","current":-3.487322,"twenty":-17.360806,"median":-9.824237,"eighty":-6.050554,"marketCap":767249277},{"date":"2024-09-27","current":-3.456269,"twenty":-17.341038,"median":-9.672861,"eighty":-6.031978,"marketCap":760417137},{"date":"2024-10-04","current":-3.630169,"twenty":-17.341038,"median":-9.390679,"eighty":-5.972448,"marketCap":798677119},{"date":"2024-10-11","current":-3.453163,"twenty":-17.341038,"median":-9.226291,"eighty":-5.909884,"marketCap":759733923},{"date":"2024-10-18","current":-3.512165,"twenty":-17.341038,"median":-9.011098,"eighty":-5.876626,"marketCap":772714988},{"date":"2024-10-25","current":-3.714014,"twenty":-17.341038,"median":-8.90989,"eighty":-5.795064,"marketCap":817123896},{"date":"2024-10-31","current":-3.760594,"twenty":-17.341038,"median":-8.768922,"eighty":-5.525809,"marketCap":827372105},{"date":"2024-11-08","current":-3.791648,"twenty":-17.205109,"median":-8.678585,"eighty":-5.069007,"marketCap":834204245},{"date":"2024-11-15","current":-3.661401,"twenty":-17.192664,"median":-8.604536,"eighty":-4.715521,"marketCap":779958861},{"date":"2024-11-22","current":-3.548989,"twenty":-17.192664,"median":-8.493293,"eighty":-3.820091,"marketCap":756012756},{"date":"2024-11-29","current":-4.522151,"twenty":-17.192664,"median":-8.424021,"eighty":-3.820091,"marketCap":963317611},{"date":"2024-12-06","current":-4.615452,"twenty":-17.192664,"median":-8.333153,"eighty":-3.820091,"marketCap":983192794},{"date":"2024-12-13","current":-4.321902,"twenty":-17.192664,"median":-8.240025,"eighty":-3.820091,"marketCap":920660225},{"date":"2024-12-20","current":-4.24763,"twenty":-17.192664,"median":-8.201035,"eighty":-3.820091,"marketCap":904838732},{"date":"2024-12-27","current":-4.523497,"twenty":-17.192664,"median":-8.13773,"eighty":-3.820091,"marketCap":963604278},{"date":"2025-01-03","current":-4.537396,"twenty":-17.192664,"median":-8.078641,"eighty":-3.820091,"marketCap":966565111},{"date":"2025-01-10","current":-4.1653,"twenty":-17.196713,"median":-8.023922,"eighty":-3.817856,"marketCap":887300616},{"date":"2025-01-17","current":-3.742629,"twenty":-17.078146,"median":-7.988903,"eighty":-3.790414,"marketCap":797262305},{"date":"2025-01-24","current":-4.967292,"twenty":-16.990879,"median":-7.962747,"eighty":-3.774419,"marketCap":1058142538},{"date":"2025-01-31","current":-4.920329,"twenty":-16.953236,"median":-7.899761,"eighty":-3.774419,"marketCap":1048138282},{"date":"2025-02-07","current":-5.079282,"twenty":-16.830086,"median":-7.844848,"eighty":-3.774419,"marketCap":1081998843},{"date":"2025-02-14","current":-4.821817,"twenty":-16.78929,"median":-7.805048,"eighty":-3.774419,"marketCap":1100541220},{"date":"2025-02-21","current":-4.828566,"twenty":-16.78929,"median":-7.774406,"eighty":-3.774419,"marketCap":1102081516},{"date":"2025-02-28","current":-4.263377,"twenty":-16.78929,"median":-7.699145,"eighty":-3.774419,"marketCap":973081757},{"date":"2025-03-07","current":-3.961381,"twenty":-16.791042,"median":-7.658931,"eighty":-3.769362,"marketCap":904153528},{"date":"2025-03-14","current":-4.001872,"twenty":-16.791042,"median":-7.643303,"eighty":-3.761336,"marketCap":913395302},{"date":"2025-03-21","current":-3.914141,"twenty":-16.791042,"median":-7.573195,"eighty":-3.761336,"marketCap":893371459},{"date":"2025-03-28","current":-3.526102,"twenty":-16.791042,"median":-7.503948,"eighty":-3.734509,"marketCap":804804461},{"date":"2025-04-04","current":-2.662291,"twenty":-16.791042,"median":-7.445715,"eighty":-3.714635,"marketCap":607646622},{"date":"2025-04-11","current":-2.334988,"twenty":-16.78929,"median":-7.411075,"eighty":-3.662101,"marketCap":532942284},{"date":"2025-04-17","current":-2.57456,"twenty":-16.78929,"median":-7.377317,"eighty":-3.643832,"marketCap":587622779},{"date":"2025-04-21","current":-2.697721,"twenty":-16.791042,"median":-7.358545,"eighty":-3.632653,"marketCap":615733174}],"updateTime":1745321158399}}}